EPA Delays PFAS Survey, AI BioDesign Accelerator Launches, Ultragenyx Drug Flops Stock Plummets, Climate Predictions Vindicated by Science, and more...

(0:10): EPA Delays PFAS Wastewater Survey, Sparking Debate Over Industry Influence and Public Health Risks(1:36): AI BioDesign Accelerator Launches with $94.6M Funding to Revolutionize Biological Engineering(3:59): Ultragenyx's Drug Failure Sparks Stock Plunge, Reassessment of Angelman Syndrome Program(6:03): 1990 IPCC Report Vindicated: Climate Change Predictions Hindered by Political Will, Not Science(7:44): Study Unveils ATRX's Crucial Role in DNA Replication and Telomere MaintenanceTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: WSOC TV